Skip to main content
Clinical Trials/NCT01765322
NCT01765322UnknownNot Applicable

Center of Assisted Reproductive Technology

Shanxi Provincial Maternity and Children's Hospital1 site in 1 country150 target enrollmentStarted: November 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
The implantation rate

Study Overview

Brief Summary

The purpose of this study is to determine whether laser-assisted zona thinning improve the implantation rate of the women of advanced age in the first IVF/ICSI cycles

Detailed Description

Registry procedures:

  1. It's required to sign an informed consent form prior to the recruitment of all patients.
  2. Data collection and entry need double check and supervision.

The outcome measures:

the implantation rate per embryo transfer miscarriage live birth

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
35 Years to 46 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age: 35y ≤age≤46y
  • Basal FSH value: FSH≤10IU/L
  • Day-3 embryos transferred in the fresh IVF/ICSI cycles
  • the number of embryos available to be transferred on Day-3: ≥one embryo

Exclusion Criteria

  • cycles with thawed/warmed embryos biopsied for PGD/PGS.
  • cycles with oocyte donation transfer.
  • the maximum number of previous unsuccessful IVF attempts: ≥ 3 cycles(transfer cycles)
  • any cycles with the risk of OHSS, fluid in the uterine cavity, abnormal endometrium, uterine abnormalities,pelvic inflammation, and other acute maternal problems.
  • One or both spouses have an abnormal karyotype (including polymorphism)

Outcomes

Primary Outcomes

The implantation rate

Time Frame: 30 days

the implantation rate per embryo in first fresh embryos transfer cycles

Secondary Outcomes

  • The miscarriage(24 weeks)

Investigators

Sponsor
Shanxi Provincial Maternity and Children's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shi Wenhao

Assisted Reproductive Technology Center

Shanxi Provincial Maternity and Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials